Cargando…
Sustained Release of Basic Fibroblast Growth Factor (bFGF) Encapsulated Polycaprolactone (PCL) Microspheres Promote Angiogenesis In Vivo
Coronary heart disease (CHD) is the leading cause of death in the Unites States and globally. The administration of growth factors to preserve cardiac function after myocardial infarction (MI) is currently being explored. Basic fibroblast growth factor (bFGF), a potent angiogenic factor has poor cli...
Autores principales: | Arunkumar, Pala, Dougherty, Julie A., Weist, Jessica, Kumar, Naresh, Angelos, Mark G., Powell, Heather M., Khan, Mahmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669517/ https://www.ncbi.nlm.nih.gov/pubmed/31330782 http://dx.doi.org/10.3390/nano9071037 |
Ejemplares similares
-
Development of a polyvinyl alcohol/sodium alginate hydrogel-based scaffold incorporating bFGF-encapsulated microspheres for accelerated wound healing
por: Bahadoran, Maedeh, et al.
Publicado: (2020) -
A Heparin-Mimicking Polymer Conjugate Stabilizes Basic Fibroblast Growth Factor (bFGF)
por: Nguyen, Thi H., et al.
Publicado: (2013) -
Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF)
por: Zhang, Xiaoyu, et al.
Publicado: (2018) -
Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells
Publicado: (1994) -
Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis
por: Pandiar, Deepak, et al.
Publicado: (2014)